These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23002965)

  • 1. Influenza vaccines and immunopathology.
    Gilbert SC
    Expert Rev Vaccines; 2012 Aug; 11(8):873-5. PubMed ID: 23002965
    [No Abstract]   [Full Text] [Related]  

  • 2. INFLUENZA. Narcolepsy link to pandemic flu vaccine becomes clearer.
    Vogel G
    Science; 2015 Jul; 349(6243):17. PubMed ID: 26138959
    [No Abstract]   [Full Text] [Related]  

  • 3. Pediatric influenza vaccination: understanding the T-cell response.
    Bodewes R; Fraaij PL; Osterhaus AD; Rimmelzwaan GF
    Expert Rev Vaccines; 2012 Aug; 11(8):963-71. PubMed ID: 23002977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal influenza vaccine: the holy grail?
    Shaw AR
    Expert Rev Vaccines; 2012 Aug; 11(8):923-7. PubMed ID: 23002973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects for broadly protective influenza vaccines.
    Treanor JJ
    Vaccine; 2015 Nov; 33 Suppl 4():D39-45. PubMed ID: 26338145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of inactivated vaccines against influenza].
    Fridman EA; Peradze TV
    Tr Inst Im Pastera; 1982; 58():84-94. PubMed ID: 6764983
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination].
    Stumpa A; Tůmová B
    Tr Inst Im Pastera; 1982; 59():23-8. PubMed ID: 6764986
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemistry. Catching a moving target.
    Wang TT; Palese P
    Science; 2011 Aug; 333(6044):834-5. PubMed ID: 21836007
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunology. Flu antibodies stir new hope for treatment, vaccine.
    Leslie M
    Science; 2009 Feb; 323(5918):1160. PubMed ID: 19251602
    [No Abstract]   [Full Text] [Related]  

  • 10. Influenza vaccines: T-cell responses deserve more attention.
    Schotsaert M; Saelens X; Leroux-Roels G
    Expert Rev Vaccines; 2012 Aug; 11(8):949-62. PubMed ID: 23002976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and protective efficacy of influenza vaccination.
    Hannoun C; Megas F; Piercy J
    Virus Res; 2004 Jul; 103(1-2):133-8. PubMed ID: 15163501
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunology. Prime, boost, and broaden.
    Doms RW
    Science; 2010 Aug; 329(5995):1021-2. PubMed ID: 20798304
    [No Abstract]   [Full Text] [Related]  

  • 13. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
    Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
    Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects for controlling future pandemics of influenza.
    Robertson JS; Inglis SC
    Virus Res; 2011 Dec; 162(1-2):39-46. PubMed ID: 21963676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
    Crank MC; Mascola JR; Graham BS
    J Infect Dis; 2019 Apr; 219(Suppl_1):S107-S109. PubMed ID: 30715413
    [No Abstract]   [Full Text] [Related]  

  • 16. Major challenges in providing an effective and timely pandemic vaccine for influenza A(H7N9).
    Osterholm MT; Ballering KS; Kelley NS
    JAMA; 2013 Jun; 309(24):2557-8. PubMed ID: 23700117
    [No Abstract]   [Full Text] [Related]  

  • 17. [Characteristics of influenza immunity and prospects of achieving virus-specific prevention of influenza].
    Shvartsman IaS; Tsybul'skaia NV; Ispolatova AV
    Usp Sovrem Biol; 1982; 94(3):446-60. PubMed ID: 6186100
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospects for universal influenza virus vaccine.
    Gerhard W; Mozdzanowska K; Zharikova D
    Emerg Infect Dis; 2006 Apr; 12(4):569-74. PubMed ID: 16704803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.
    Schmidt T; Dirks J; Enders M; Gärtner BC; Uhlmann-Schiffler H; Sester U; Sester M
    Eur J Immunol; 2012 Jul; 42(7):1755-66. PubMed ID: 22585549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computationally optimized antigens to overcome influenza viral diversity.
    Giles BM; Ross TM
    Expert Rev Vaccines; 2012 Mar; 11(3):267-9. PubMed ID: 22380818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.